Skip to main content
. 2022 May 9;24(7):1338–1350. doi: 10.1111/dom.14710

FIGURE 1.

FIGURE 1

Change from baseline in A, glycated haemoglobin (HbA1c), and B, body weight, by baseline age. Abbreviations: flex, flexibly dosed; OAD, oral antidiabetes drug; SGLT2i, sodium‐glucose cotransporter‐2 inhibitor; SU, sulphonylurea. Including metformin, an SU, an SGLT2i or a thiazolidinedione. Analyses were conducted at the end of treatment on data from the full analysis set using the trial product estimand. The P value indicates a significant treatment‐by‐subgroup interaction with regard to the estimated treatment differences for that trial (two‐sided significance test)